Product Overview
BPC-157 + TB-500 is a combined peptide formulation supplied for use in controlled laboratory and research environments.
This blend combines two extensively studied synthetic peptide compounds frequently investigated in preclinical research models relating to cellular signalling, tissue-level interactions, peptide stability, and recovery-associated biological processes.
BPC-157 is a synthetic peptide fragment derived from a protective protein sequence, while TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide involved in cellular migration and structural organisation research.
The combined formulation is commonly utilised in controlled experimental settings examining synergistic peptide behaviour, biological response mechanisms, and laboratory reproducibility under standardised conditions.
Supplied in lyophilised form, each vial is prepared to support precision handling, consistency, and controlled laboratory application.
Verification Standard
Every batch of BPC-157 + TB-500 supplied by Peptology Labs undergoes a controlled, batch-specific verification process:
- High-Performance Liquid Chromatography (HPLC) purity analysis
- Mass spectrometry (LC-MS) identity confirmation
- Independently tested by a third-party analytical laboratory
- Additional verification through internationally recognised analytical partners such as Janoshik Analytical
Batch-specific Certificates of Analysis (COAs) are provided for full transparency and traceability.
Product Specification
- Quantity: 10mg blend per vial
- Form: Lyophilised powder
- Purity: ≥99% (HPLC)
- Verification: Independently tested (batch specific)
- Storage: Store refrigerated in a dry environment
- Intended Use: Research use only. Not for human or veterinary use.
